Feb 23, 2022 / 10:00PM GMT
Operator
Thank you for standing by, and welcome to the Imricor Medical FY '21 Results Briefing. (Operator Instructions)
I would now like to hand the conference over to Mr. Steve Wedan, Chair and CEO. Please go ahead.
Steve Wedan - Imricor Medical Systems, Inc. - CEO, President & Executive Chairman
Hello, everyone, and thank you for joining us today to discuss Imricor's full year results. I'm Steve Wedan, Imricor's Chair and CEO, and I'm joined today by our CFO, Lori Milbrandt.
Today, we'll provide you with the business update on the progress we've made during 2021, including our key achievements and the progress we've made on our overall strategy. Lori will then discuss the financial results before I review our market opportunity and the outlook for the remainder of this year. We will then move to a Q&A session.
So despite the challenges of the pandemic, Imricor has delivered on a number of strong outcomes and key achievements in 2021. These achievements are highlighted on Slide 3 (sic) [Slide 5]: Signed 5 new sites through the year
Q4 2021 Imricor Medical Systems Inc Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot